These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25311651)

  • 21. Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women.
    Olmedilla-Alonso B; Estévez-Santiago R; Silván JM; Sánchez-Prieto M; de Pascual-Teresa S
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30044439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
    Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM
    Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementation with all three macular carotenoids: response, stability, and safety.
    Connolly EE; Beatty S; Loughman J; Howard AN; Louw MS; Nolan JM
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9207-17. PubMed ID: 21979997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
    Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of macular pigment and contrast threshold in Spanish healthy normolipemic subjects (45-65 years) with habitual food intake.
    Olmedilla-Alonso B; Rodríguez-Rodríguez E; Beltrán-de-Miguel B; Estévez-Santiago R; Sánchez-Prieto M
    PLoS One; 2021; 16(5):e0251324. PubMed ID: 34043644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.
    Nolan JM; Akkali MC; Loughman J; Howard AN; Beatty S
    Exp Eye Res; 2012 Aug; 101():9-15. PubMed ID: 22652506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of macular pigment optical density with serum concentration of oxidized low-density lipoprotein in healthy adults.
    Nagai N; Izumi-Nagai K; Suzuki M; Shinoda H; Koto T; Uchida A; Mochimaru H; Tomita Y; Miyake S; Kobayashi S; Sasaki M; Tsubota K; Ozawa Y
    Retina; 2015 Apr; 35(4):820-6. PubMed ID: 25473786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E genotype is associated with macular pigment optical density.
    Loane E; McKay GJ; Nolan JM; Beatty S
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
    Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
    Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
    Dietzel M; Zeimer M; Heimes B; Claes B; Pauleikhoff D; Hense HW
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3452-7. PubMed ID: 21296816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study.
    Dawczynski J; Jentsch S; Schweitzer D; Hammer M; Lang GE; Strobel J
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2711-23. PubMed ID: 23695657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
    Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
    Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatial profile of macular pigment and its relationship to foveal architecture.
    Nolan JM; Stringham JM; Beatty S; Snodderly DM
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.
    Schalch W; Cohn W; Barker FM; Köpcke W; Mellerio J; Bird AC; Robson AG; Fitzke FF; van Kuijk FJ
    Arch Biochem Biophys; 2007 Feb; 458(2):128-35. PubMed ID: 17084803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
    Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships of Macular Pigment Optical Density With Plasma Lutein, Zeaxanthin, and Diet in an Elderly Population: The Montrachet Study.
    Alassane S; Binquet C; Cottet V; Fleck O; Acar N; Daniel S; Delcourt C; Bretillon L; Bron AM; Creuzot-Garcher C
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1160-7. PubMed ID: 26975027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.
    Kelly D; Coen RF; Akuffo KO; Beatty S; Dennison J; Moran R; Stack J; Howard AN; Mulcahy R; Nolan JM
    J Alzheimers Dis; 2015; 48(1):261-77. PubMed ID: 26401946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative.
    Mares JA; LaRowe TL; Snodderly DM; Moeller SM; Gruber MJ; Klein ML; Wooten BR; Johnson EJ; Chappell RJ;
    Am J Clin Nutr; 2006 Nov; 84(5):1107-22. PubMed ID: 17093164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults.
    Renzi-Hammond LM; Bovier ER; Fletcher LM; Miller LS; Mewborn CM; Lindbergh CA; Baxter JH; Hammond BR
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29135938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.